Status:
COMPLETED
Placebo Controlled Trial of Botulinum Toxin for Gastroparesis
Lead Sponsor:
Temple University
Collaborating Sponsors:
American College of Gastroenterology
Conditions:
Gastroparesis
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
It is hypothesized that in some patients with gastroparesis increased pyloric tone may be a contributing feature. Botox relaxes the pylorus so that food can empty the stomach more rapidly. Lesser qual...
Detailed Description
Patients with gastroparesis, or delayed gastric emptying, present with early satiety, postprandial bloating, nausea, vomiting, and abdominal pain or discomfort.1 Gastric emptying is a highly regulated...
Eligibility Criteria
Inclusion
- Documented gastroparesis by radiologic study
- No ulcer disease
- Only surgery history must be either appendectomy or cholecystectomy
- No prior treatment with Botox
Exclusion
- Prior botox injection
Key Trial Info
Start Date :
July 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT00372970
Start Date
July 1 2003
End Date
December 1 2008
Last Update
June 9 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Temple University Hospital
Philadelphia, Pennsylvania, United States, 19140